Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Serena Trubini"'
Autor:
Elena Orlandi, Mario Giuffrida, Serena Trubini, Enrico Luzietti, Massimo Ambroggi, Elisa Anselmi, Patrizio Capelli, Andrea Romboli
Publikováno v:
Diagnostics, Vol 14, Iss 10, p 1001 (2024)
Microsatellite Instability (MSI-H) occurs in approximately 15% of non-metastatic colon cancers, influencing patient outcomes positively compared to microsatellite stable (MSS) cancers. This systematic review focuses on the prognostic significance of
Externí odkaz:
https://doaj.org/article/2bc49396278849bfaa4c73abf4596ceb
Autor:
ELENA ORLANDI, ANDREA ROMBOLI, CHIARA CITTERIO, SERENA TRUBINI, STEFANO VECCHIA, MARIA ANGELA PALLADINO, PATRIZIO CAPELLI, LUIGI CAVANNA
Publikováno v:
Anticancer Research. 43:2015-2024
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e8a287ad0745cc1fff104385dfb96a1
https://doi.org/10.21873/anticanres.16362
https://doi.org/10.21873/anticanres.16362
Autor:
Giulia Mazzaschi, Fabiana Perrone, Roberta Minari, Michela Verzè, Cinzia Azzoni, Lorena Bottarelli, Monica Pluchino, Maria Pia Armillotta, Annalisa Ubaldi, Annalisa Altimari, Elisa Gruppioni, Francesca Sperandi, Elisa Andrini, Giorgia Guaitoli, Stefania Bettelli, Lucia Longo, Federica Bertolini, Fausto Barbieri, Maria Pagano, Candida Bonelli, Elena Tagliavini, Davide Nicoli, Alessandro Ubiali, Adriano Zangrandi, Serena Trubini, Manuela Proietto, Letizia Gnetti, Marcello Tiseo
Publikováno v:
Clinical Lung Cancer. 23:e478-e488
Targeting Kirsten Rat Sarcoma (KRAS) has been deemed impossible for long time, but new drugs have recently demonstrated promising results. Evidence on the outcome of KRAS-mutant advanced-NSCLC treated with new standard regimens are still scarce. Thus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7053999a8fa97bfc0f7fa4b0494b6c82
https://doi.org/10.1016/j.cllc.2022.07.005
https://doi.org/10.1016/j.cllc.2022.07.005
Autor:
Fabiana Perrone, Giulia Mazzaschi, Roberta Minari, Michela Verzè, Cinzia Azzoni, Lorena Bottarelli, Rita Nizzoli, Monica Pluchino, Annalisa Altimari, Elisa Gruppioni, Francesca Sperandi, Elisa Andrini, Giorgia Guaitoli, Federica Bertolini, Fausto Barbieri, Stefania Bettelli, Lucia Longo, Maria Pagano, Candida Bonelli, Elena Tagliavini, Davide Nicoli, Alessandro Ubiali, Adriano Zangrandi, Serena Trubini, Manuela Proietto, Letizia Gnetti, Marcello Tiseo
Publikováno v:
Cancers; Volume 14; Issue 8; Pages: 2019
Introduction: BRAF mutation involved 2–4% of lung adenocarcinoma. Differences in clinicopathologic features and patient outcome exist between V600E and non-V600E BRAF mutated NSCLC. Thus, we sought to assess the frequency and clinical relevance of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53b1c1e8917f636ad5da3248d3650b3f
Autor:
Luigi Cavanna, P. Mordenti, Monica Muroni, Anna Lis, Elisabetta Marazzi, Giulia Bandieramonte, Daniele Vallisa, Nicoletta Bacchetta, Giuliana Lo Cascio, Serena Madaro, Chiara Citterio, G. Cremona, Claudia Biasini, Roberta Schiavo, Patrizia Bernuzzi, Maristella Tassi, Maria Mariano, Martina Mutti, Serena Trubini, Raffaella Maestri
Publikováno v:
European Journal of Cancer
Introduction Patients with cancer are presumed a frail group at high risk of contracting coronavirus disease (COVID-19), and vaccination represents a cornerstone in addressing the COVID-19 pandemic. However, data on COVID-19 vaccination in cancer pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1277344dd6704a77fd75435f0088b726
http://europepmc.org/articles/PMC8410513
http://europepmc.org/articles/PMC8410513
Publikováno v:
Molecular and Clinical Oncology.
In melanoma, a number of specific genetic and genomic aberrations have been identified to be important in tumorigenesis. In particular, the mutant B-Raf proto-oncogene, Serine/Threonine kinase (BRAF) gene is the target of tailored therapy with kinase
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4847fabafd4c11a36791a7ede2908e9d
https://doi.org/10.3892/mco.2018.1555
https://doi.org/10.3892/mco.2018.1555
Autor:
Eleonora Toffoletti, Valentina Marchica, Vinicio Fazio, Filippo Gherlinzoni, Marzia Salvucci, Piero Galieni, Meris Donati, Luisa Toffolatti, Daniele Vallisa, Francesca Cassavia, Serena Trubini, Stefania Mancini, Donato Gemmati, C Bolzonella, Francesco Orsini, Vèronique Laloux, Sara Barulli, Mirija Svaldi, Cristina Salbe, Marco Manfrini, Silvia Di Zacomo, Giorgia Maccari, Annamaria Fioroni, Milena Gusella, Patrizia Zucchini, Monica Maccaferri, Nicola Giuliani, Massimiliano Bonifacio, Mosè Favarato, Maria Luisa Serino, Emanuela Ottaviani, Patrizia Accorsi, Barbara Giannini, Enrica Bellesia, Francesca Palandri, Mario Angelini, Daniela Gatti, Giovanna De Matteis, Linda Orlandi, Filippo Navaglia, Giovanni Martinelli, Alessia Tieghi, Laura Bagli, Anna Rita Scortechini, Margherita Perricone
Publikováno v:
Oncotarget
// Margherita Perricone 1 , Francesca Palandri 1 , Emanuela Ottaviani 1 , Mario Angelini 2 , Laura Bagli 3 , Enrica Bellesia 4 , Meris Donati 5 , Donato Gemmati 6 , Patrizia Zucchini 7 , Stefania Mancini 8 , Valentina Marchica 9 , Serena Trubini 10 ,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fda51de2c760f48b0a8481977d2151a
https://pubmed.ncbi.nlm.nih.gov/28427233
https://pubmed.ncbi.nlm.nih.gov/28427233